Lakewood-Amedex Biotherapeutics Inc. (LABT)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.39
- As of
Kresmion compiles this page from LABT's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Lakewood-Amedex Biotherapeutics Inc. (LABT): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-29.
See the full LABT dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for LABT on one page. Preview it with sample data, then open it live with a free account.
Preview the LABT dossierActive events for LABT
No recent events on LABT in the last 180 days.
FREE, NO ACCOUNT
Every event on LABT, as it fires
New filings, 13F moves and cross asset events on LABT land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, LABT
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
LABT's 10-Q filed Aug 14, 2026 states:
These conditions raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the condensed financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on LABT
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in LABT on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on LABT in the last 180 days.
Upstream: SEC EDGAR filings for LABT
Kresmion, "Lakewood-Amedex Biotherapeutics Inc. (LABT) institutional holdings and SEC filings", data as of 2026-09-29, https://kresmion.com/research/LABT. Upstream data: SEC EDGAR filings for LABT.
Link to this data (HTML):
<a href="https://kresmion.com/research/LABT">Lakewood-Amedex Biotherapeutics Inc. (LABT) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow LABT on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to LABT for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.